Literature DB >> 24651639

Ketamine: an update on its abuse.

Gyula Bokor1, Peter D Anderson2.   

Abstract

Ketamine is a dissociative anesthetic and substance of abuse. Numerous effects can result from the abuse of ketamine. Death from acute direct toxicity is rare. Ketamine can alter numerous functions in the brain including color perception, memory, attention, cognition, reaction time, and sense of time and can produce psychological addiction. Chronic ketamine abuse can produce toxicity to the gastrointestinal and urinary tract. Gastrointestinal changes include epigastric pain, hepatic dysfunction, and impaired gallbladder activity. The most common urological condition from ketamine is cystitis but renal failure has been reported.
© The Author(s) 2014.

Entities:  

Keywords:  drug information; nephrology; psychopharmacology; substance abuse; toxicology

Mesh:

Substances:

Year:  2014        PMID: 24651639     DOI: 10.1177/0897190014525754

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  24 in total

1.  Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction.

Authors:  Retnagowri Rajandram; Teng Aik Ong; Azad H A Razack; Bryce MacIver; Mark Zeidel; Weiqun Yu
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-24

2.  Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.

Authors:  Jana Ruda-Kucerova; Zuzana Babinska; Tibor Stark; Vincenzo Micale
Journal:  Neurotox Res       Date:  2017-04-18       Impact factor: 3.911

Review 3.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 4.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 5.  Ketamine: The final frontier or another depressing end?

Authors:  Omar K Sial; Eric M Parise; Lyonna F Parise; Tamara Gnecco; Carlos A Bolaños-Guzmán
Journal:  Behav Brain Res       Date:  2020-02-01       Impact factor: 3.332

6.  Long-lasting effects of repeated ketamine administration in adult and adolescent rats.

Authors:  M L Shawn Bates; Keith A Trujillo
Journal:  Behav Brain Res       Date:  2019-04-26       Impact factor: 3.332

7.  Management of Ketamine Extravasation in a Pediatric Patient During Procedural Sedation.

Authors:  Samantha A Smith; Casey T Fitzpatrick; Courtney L Olesky; Ashley B Litchfield
Journal:  J Pediatr Pharmacol Ther       Date:  2022-03-21

8.  Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Effects of This Psychoactive Drug.

Authors:  Danyon J Anderson; Jessica Zhou; David Cao; Matthew McDonald; Maya Guenther; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-09-15

Review 9.  Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.

Authors:  Marko A Peltoniemi; Nora M Hagelberg; Klaus T Olkkola; Teijo I Saari
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

10.  Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls.

Authors:  Liang-Jen Wang; Chih-Ken Chen; Shih-Ku Lin; Yi-Chih Chen; Ke Xu; Ming-Chyi Huang
Journal:  Psychopharmacology (Berl)       Date:  2018-04-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.